ACTG (AIDS Clinical Trials Group) 384: A Strategy Trial Comparing Consecutive Treatments for HIV-1

ACTG (AIDS Clinical Trials Group) 384 is designed to evaluate different strategies for antiretroviral treatment in HIV-1-infected individuals with no previous exposure to antiretroviral treatment. The study is a randomized, partially double-blinded, controlled trial with 980 subjects at 81 centers i...

Full description

Saved in:
Bibliographic Details
Published in:Control Clin Trials
Main Authors: Smeaton, Laura M., DeGruttola, Victor, Robbins, Gregory K., Shafer, Robert W.
Format: Artigo
Language:Inglês
Published: 2001
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767253/
https://ncbi.nlm.nih.gov/pubmed/11306153
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items